SecurityAKAO / Achaogen, Inc. (004449104)
IndustryPharmaceutical Preparations
Institutional Owners115
Institutional Shares28,872,220 - 63.86%
Common Shares Outstanding45,209,423 shares (as of 2018-06-30)
Institutional Value$ 12,576,114,000 USD

Institutional Stock Ownership and Shareholders()

AKAO / Achaogen, Inc. Institutional Ownership

Achaogen, Inc. (NASDAQ:AKAO) has 115 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,872,220 shares. Largest shareholders include NEA Management Company, LLC, State Street Corp, Foresite Capital Management III, LLC, BlackRock Inc., FMR LLC / Fidelity, Vanguard Group Inc, Versant Venture Management, LLC, TimesSquare Capital Management, LLC, Axa, and EverPoint Asset Management, LLC.
Achaogen, Inc. (NASDAQ:AKAO) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-06 13F-HR Granite Investment Partners, LLC 16,251 0 -100.00 211 0 -100.00
2018-08-06 13F-HR Sonora Investment Management, LLC 1,000 1,000 0.00 12,950 9 -99.93
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. Put 31,900 29,900 -6.27 242 362 49.59
2018-08-14 13F-HR Marshall Wace North America L.P. 22,475 195
2018-08-06 13F-HR RHUMBLINE ADVISERS 31,970 30,685 -4.02 414 266 -35.75
2018-07-30 13F-HR Harel Insurance Investments & Financial Services Ltd. 5,000 43
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 16,696 17,786 6.53 216 154 -28.70
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 351,670 78,618 -77.64 4,554 681 -85.05
2018-08-14 13F-HR HARBOURVEST PARTNERS LLC 20,000 20,000 0.00 259 173 -33.20
2017-02-14 13F-HR EverPoint Asset Management, LLC 675,000 8,789
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. Call 0 79,400 0 40
2018-08-14 13F-HR STIFEL FINANCIAL CORP 10,391 0 -100.00 134 0 -100.00
2017-02-10 13F-HR BlackRock Japan Co. Ltd 0 829 0 11
2018-08-10 13F-HR Quantitative Investment Management, LLC 93,700 26,900 -71.29 1,213 232 -80.87
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 103,851 430,796 314.82 497 5,609 1,028.57
2018-05-11 13F-HR CITIGROUP INC 92,949 105,197 13.18 998 1,362 36.47
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 31,000 91,668 195.70 402 794 97.51
2018-08-14 13F-HR Premier Asset Managment LLC 30,953 0 -100.00 401 0 -100.00
2018-08-01 13F-HR FIRST MIDWEST BANK TRUST DIVISION 100,091 47,138 -52.90 1,296 408 -68.52
2018-08-14 13F-HR UBS OCONNOR LLC 0 100,000 0 866,000
2018-07-13 13F-HR Versant Venture Management, LLC 1,281,152 1,281,152 0.00 16,590,918 11,094,776 -33.13
2018-08-14 13F-HR Sabby Management, LLC Put 1,405 0 -100.00 1,819 0 -100.00
2018-08-15 13F-HR JANE STREET GROUP, LLC 32,008 0 -100.00 415 0 -100.00
2017-02-10 13F-HR BlackRock Fund Advisors 60,100 72,653 20.89 288 946 228.47
2018-08-14 13F-HR DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 31,122 0 -100.00 403 0 -100.00
2018-08-10 13F-HR GAMCO INVESTORS, INC. ET AL 66,200 94,700 43.05 857 820 -4.32
2018-08-13 13F-HR Allianz Asset Management AG 92,781 92,244 -0.58 1,202 799 -33.53
2018-08-14 13F-HR Prosight Management, LP 661,054 375,000 -43.27 8,561 3,248 -62.06
2018-07-12 13F-HR CHESLEY TAFT & ASSOCIATES LLC/IL 18,075 19,815 9.63 234 172 -26.50
2018-08-14 13F-HR CREDIT SUISSE AG/ 33,373 25,110 -24.76 432 218 -49.54
2017-08-08 13F-HR Airain ltd 31,507 685
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 52,899 198,204 274.68 685 1,717 150.66
2018-07-18 13F-HR Fny Investment Advisers, Llc Call 4 0
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 21,839 20,452 -6.35 283 177 -37.46
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ Put 29,000 86,700 198.97 376 751 99.73
2018-08-03 13F-HR Cable Hill Partners, LLC 2,000 4,000 100.00 24 35 45.83
2018-08-14 13F-HR TEACHERS ADVISORS INC 76,794 77,059 0.35 994 667 -32.90
2018-08-06 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 1,712 1,712 0.00 22 15 -31.82
2018-08-13 13F-HR BLAIR WILLIAM & CO/IL 43,129 57,554 33.45 559 498 -10.91
2018-08-14 13F-HR D. E. Shaw & Co., Inc. 39,847 0 -100.00 516 0 -100.00
2018-08-14 13F-HR Weiss Multi-Strategy Advisers LLC 24,180 0 -100.00 313 0 -100.00
2018-08-13 13F-HR ICONIQ Capital, LLC 28,629 0 -100.00 371 0 -100.00
2018-08-14 13F-HR VANGUARD GROUP INC 1,524,986 1,546,044 1.38 19,748 13,389 -32.20
2018-08-09 13F-HR Swiss National Bank 50,000 50,000 0.00 648 433 -33.18
2018-08-13 13F-HR ProShare Advisors LLC 25,046 22,962 -8.32 324 199 -38.58
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Put 61,300 322,200 425.61 794 2,790 251.39
2018-06-25 13F-HR Mount Yale Investment Advisors, Llc 1,031 13
2018-08-14 13F-HR BARCLAYS PLC Put 30,000 0 -100.00 389 0 -100.00
2018-08-15 13F-HR JANE STREET GROUP, LLC Call 16,600 144
2018-07-19 13F-HR Ballentine Partners, LLC 19,823 19,823 0.00 257 172 -33.07
2018-08-10 13F-HR Cutler Group LP Put 2,700 3,300 22.22 2 6 200.00
2018-08-02 13F-HR Fiera Capital Corp 165,457 151,683 -8.32 2,143 1,314 -38.68
2018-08-07 13F-HR IFP Advisors, Inc 219 0 -100.00 3 0 -100.00
2018-05-15 13F-HR Iguana Healthcare Management, LLC 75,000 100,000 33.33 806 1,295 60.67
2018-08-14 13F-HR JP Morgan Chase & Co 10,578 10,361 -2.05 137 90 -34.31
2018-08-03 13F-HR Engineers Gate Manager LP 97,817 0 -100.00 1,267 0 -100.00
2018-08-10 13F-HR Teton Advisors, Inc. 33,000 140,000 324.24 427 1,212 183.84
2018-08-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 10,899 10,899 0.00 141,142 94,385 -33.13
2018-08-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 30,496 264,095
2018-08-14 13F-HR Voya Investment Management LLC 15,435 13,932 -9.74 200 121 -39.50
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 57,612 0 499
2018-08-10 13F-HR Legal & General Group Plc 6,236 5,226 -16.20 80 45 -43.75
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC Put 55,000 476
2018-08-14 13F-HR DSC Advisors, L.P. Put 50,000 433
2018-08-07 13F-HR Marcus Capital, LLC 19,650 22,175 12.85 254 192 -24.41
2018-08-14 13F-HR AlpInvest Partners B.V. 21,886 16,994 -22.35 283 147 -48.06
2018-08-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 31,200 0 -100.00 404 0 -100.00
2018-08-10 13F-HR Pacad Investment Ltd. 900 0 -100.00 11 0 -100.00
2018-08-06 13F-HR Belpointe Asset Management Llc 19,300 19,300 0.00 250 167 -33.20
2018-04-18 13F-HR/A FNY Managed Accounts LLC Call 4 0
2018-08-03 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 22,000 22,000 0.00 285 191 -32.98
2018-08-14 13F-HR Foresite Capital Management III, LLC 2,850,000 2,874,418 0.86 36,908 24,892 -32.56
2018-08-13 13F-HR GROUP ONE TRADING, L.P. Put 165,800 306,800 85.04 2,147 2,657 23.75
2018-07-30 13F-HR SIMPLEX TRADING, LLC Put 53 287 441.51 3 248 8,166.67
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 2,546 2,546 0.00 33 22 -33.33
2018-08-13 13F-HR RMB Capital Management, LLC 127,407 66,856 -47.53 1,650 579 -64.91
2018-08-10 13F-HR Cutler Group LP Call 1,700 5,700 235.29 2 2 0.00
2018-07-19 13F-HR FRED ALGER MANAGEMENT INC 5,000 0 -100.00 65 0 -100.00
2018-08-09 13F-HR NEA Management Company, LLC 5,215,128 5,215,128 0.00 67,536 45,163 -33.13
2018-07-30 13F-HR Daiwa Securities Group Inc. 234 234 0.00 3 2 -33.33
2018-08-13 13F-HR ALLIANCEBERNSTEIN L.P. 59,600 60,700 1.85 772 526 -31.87
2018-08-01 13F-HR Hikari Power Ltd 60,000 60,000 0.00 777 520 -33.08
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Call 104,700 221,600 111.65 1,356 1,919 41.52
2018-08-13 13F-HR Oz Management LP Put 194,900 469,700 141.00 2,524 4,068 61.17
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 102,305 284,317 177.91 1,325 2,462 85.81
2018-08-06 13F-HR Bank of New York Mellon Corp 145,131 142,744 -1.64 1,880 1,235 -34.31
2018-08-10 13F-HR GABELLI FUNDS LLC 174,000 206,400 18.62 2,253 1,787 -20.68
2018-08-15 13F-HR Metlife Investment Advisors, Llc 14,077 14,077 0.00 182 122 -32.97
2018-08-14 13F-HR TimesSquare Capital Management, LLC 1,284,411 1,216,611 -5.28 16,633 10,536 -36.66
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 51,803 48,047 -7.25 671 416 -38.00
2018-08-03 13F-HR SEI INVESTMENTS CO 0 48,846 0 423
2018-08-14 13F-HR Sabby Management, LLC Call 713 0 -100.00 923 0 -100.00
2018-08-14 13F-HR NORTHERN TRUST CORP 376,128 372,221 -1.04 4,870 3,224 -33.80
2018-08-10 13F-HR Summit Trail Advisors, Llc 1,172 0 -100.00 1 0 -100.00
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 79,911 73,700 -7.77 1,035 638 -38.36
2018-08-14 13F-HR Alyeska Investment Group, L.P. 198,214 0 -100.00 2,567 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 1,000 13
2018-07-18 13F-HR Fny Investment Advisers, Llc 500 4
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 32,500 42,050 29.38 421 364 -13.54
2018-08-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 1,010,008 134,350 -86.70 13,080 1,163 -91.11
2017-02-10 13F-HR BlackRock Investment Management, LLC 3,744 3,744 0.00 18 49 172.22
2018-08-10 13F-HR FMR LLC / Fidelity 3,764,966 1,673,395 -55.55 48,756 14,492 -70.28
2018-08-14 13F-HR Candriam Luxembourg S.C.A. 222,555 127,555 -42.69 2,882 1,105 -61.66
2018-08-14 13F-HR BARCLAYS PLC 40,096 7,371 -81.62 520 64 -87.69
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 52,901 43,456 -17.85 685 377 -44.96
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 2,200 2,200 0.00 29 19 -34.48
2018-08-08 13F-HR US BANCORP \DE\ 4,809 3,315 -31.07 62 29 -53.23
2017-02-13 SC 13G/A ARCH VENTURE FUND VI LP 1,418,657
2018-08-10 13F-HR Cutler Group LP 1,000 300 -70.00 12 2 -83.33
2018-07-30 13F-HR SIMPLEX TRADING, LLC 0 28,755 0 249
2018-07-20 13F-HR Creative Planning 71,160 33,775 -52.54 922 292 -68.33
2018-08-16 13F-HR/A COWEN GROUP, INC. Put 22,900 0 -100.00 297 0 -100.00
2018-08-14 13F-HR Foresite Capital Management III, LLC Put 200,000 0 -100.00 2,600 0 -100.00
2018-08-13 13F-HR GROUP ONE TRADING, L.P. Call 89,500 175,700 96.31 1,159 1,522 31.32
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 160,830 157,196 -2.26 2,083 1,362 -34.61
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 545 5
2018-08-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 62,040 537
2018-08-03 13F-HR WEDBUSH SECURITIES INC 25,050 91,850 266.67 324 795 145.37
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 0 152,314 0 1,319
2018-08-03 13F-HR Financial Architects, Inc 2,253 1,753 -22.19 29 15 -48.28
2018-02-09 13F-HR RidgeWorth Capital Management LLC 0 31,243 0 336
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 11,675 11,875 1.71 151 103 -31.79
2018-08-13 13F-HR Renaissance Technologies LLC 423,800 423,800 0.00 5,488 5,488 0.00
2018-07-19 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 800 800 0.00 10 7 -30.00
2018-08-14 13F-HR FLAGSHIP HARBOR ADVISORS, LLC 7,522 65
2018-08-14 13F-HR STATE STREET CORP 3,103,029 3,386,483 9.13 40,182 29,328 -27.01
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 93,190 92,340 -0.91 1,207 800 -33.72
2018-08-14 13F-HR LORD, ABBETT & CO. LLC 365,203 324,409 -11.17 4,730 2,809 -40.61
2018-08-09 13F-HR BlackRock Inc. 2,898,459 2,806,902 -3.16 37,536 24,307 -35.24
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 26,722 25,161 -5.84 346 218 -36.99
2018-08-06 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 600 600 0.00 8 5 -37.50
2018-08-14 13F-HR SIGNATUREFD, LLC 3 3 0.00 0 0
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 259,200 385,200 48.61 3,357 3,336 -0.63
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 0 13,591 0 118
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 365,000 402,200 10.19 4,727 3,483 -26.32
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 303,152 333,606 10.05 3,925 2,888 -26.42
2018-08-13 13F-HR Axa 615,139 687,436 11.75 7,966 5,953 -25.27
2018-08-13 13F-HR WEXFORD CAPITAL LP 17,500 152
2018-08-13 13F-HR INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 200 0 -100.00 3 0 -100.00
2018-08-14 13F-HR DEUTSCHE BANK AG\ 474,271 57,826 -87.81 6,140 499 -91.87
2018-08-14 13F-HR DekaBank Deutsche Girozentrale 16,500 16,500 0.00 207 147 -28.99
2018-08-13 13F-HR Oz Management LP 194,900 465,300 138.74 2,524 4,029 59.63
2018-08-02 13F-HR Atlantic Trust Group, LLC 12 0 -100.00 0 0
2018-08-15 13F-HR GRANAHAN INVESTMENT MANAGEMENT INC/MA 140,861 1,220
2017-02-10 13F-HR BlackRock Group LTD 38,834 22,304 -42.57 186 290 55.91
2018-07-31 13F-HR TD ASSET MANAGEMENT INC 40,226 0 -100.00 521 0 -100.00
2018-08-14 13F-HR UBS Group AG 297,632 2,500 -99.16 3,854 22 -99.43
2018-08-14 13F-HR Wellington Management Group LLP 40,414 54,544 34.96 524 473 -9.73
2018-08-03 13F-HR Clear Harbor Asset Management, LLC 14,710 16,054 9.14 190 139 -26.84
2018-08-14 13F-HR ROYAL BANK OF CANADA 55 1,217 2,112.73 0 11
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 7,403 1,237 -83.29 95,869 10,712 -88.83
2018-08-10 13F-HR CITIGROUP INC 105,197 97,615 -7.21 1,362 845 -37.96
2018-07-11 13F-HR Gierl Augustine Investment Management Inc 1,000 1,500 50.00 13 13 0.00
2018-08-14 13F-HR MORGAN STANLEY 178,022 190,303 6.90 2,305 1,647 -28.55
2018-08-13 13F-HR GROUP ONE TRADING, L.P. 61,663 142,087 130.43 799 1,230 53.94
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 754 0 -100.00 10 0 -100.00
2018-08-14 13F-HR Point72 Asset Management, L.P. Put 205,000 0 -100.00 2,655 0 -100.00
AKAO : Achaogen Stock Analysis and Research Report

2017-11-08 - Asif

Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterial treatments against multi-drug resistant (“MDR”) gram-negative infections. Achaogen is researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (“cUTI”), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (“CRE”). In 2013, the Centers for Disease Control and Prevention identified CRE as a “nightmare bacteria” and an immediate public health threat that requires “urgent and aggressive action” and in 2017 the World Health Organization identified CRE as a Global Priority 1 Pathogen: Critical Need for Research and Development of New Antibiotics. On December 12, 2016, the company announced positive data from its two Phase 3 clinical trials for plazomicin. The firs...

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

Related News Stories

Our First Look At Spero Therapeutics

6h seekingalpha
Antibiotics concern Spero Therapeutics recently used a positive interim Phase 1 readout on its lead candidate (SPR994) as an opportunity to execute a secondary offering. (14-0)

New Strong Sell Stocks for August 7th

2018-08-07 zacks
Achaogen, Inc. (AKAO - Free Report) engages in discovery, development, and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days. (18-2)

Achaogen's (AKAO) CEO Blake Wise on Q2 2018 Results - Earnings Call Transcript

2018-08-07 seekingalpha
Good day, everyone. And welcome to the Achaogen Incorporated Second Quarter 2018 Earnings Call. Today's call is being recorded. At this time, I'd like to turn the conference over to Gary Loeb, General Counsel. Please go ahead, sir. (19-3)

Achaogen (AKAO) Reports Q2 Loss, Tops Revenue Estimates

2018-08-06 zacks
Achaogen (AKAO - Free Report) just came out with a quarterly loss of $1.20 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to loss of $0.78 per share a year ago. These figures are adjusted for non-recurring items. (15-1)

CUSIP: 004449104